Latest Breaking News On - Off target aes - Page 1 : comparemela.com

Javier Pinilla, MD, PhD, provides a brief overview of the changing CLL treatment landscape, discussing the influence of off-target adverse events and the development of treatment resistance on the evolution of BTK inhibitor therapy.

Javier pinillaExploring therapeutic advancementsChronic lymphocytic leukemiaTreatment resistanceTherapy strategiesOff target aesOff target adverse eventsAdverse eventsFirst line therapyFrontline treatmentCll treatmentChronic lymphocytic leukemia treatment